Released Nov 17, 2014, before the open
10-Q filed Nov 17, 2014, 48 days after period end · 0001144204-14-069040
Q3 2014 · 10-Q
Revenue—
Net Income-$11.02M-$11.02M N/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$1.33-$1.33 N/M vs Q3 2013N/M vs Q2 2014
Operating Income-$11,055,440N/M
Operating Cash Flowderived-$3,875,127—
Free Cash Flowderived-$3,893,064—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Net Income | -$11.02M | -$4.88M | -$5.36M | -$5.80M |
| EPS Diluted | -$1.33 | -$1.23 | -$0.41 | -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR